Disclosure(s): No relevant financial relationship(s) to disclose.
Disclosure(s):
Hina Faisal, MD,: No relevant financial relationship(s) to disclose.
Plan to review the following: -which patient populations to consider using nerve blocks in and which to avoid (coagulopathy, allergies, risk of complications, etc) -agent selection/options and dosing -precautions and monitoring -technique (anatomical placement, qualified personnel, necessary training) -real-world data on clinical utility of TAP blocks (clinical trials and expert opinion from experienced speaker)
Presentations in this session: Transversus Abdominis Plane (TAP) blocks for peri-operative pain management - Hina Faisal, MD; MRCS; MBBS Ketamine's growing role in opioid-sparing analgesic initiatives - Luma Succar, PharmD, BCCCP Incorporating systemic lidocaine into multimodal pain regimens - Chelsea N. Lopez, PharmD, BCCCP Adjunct agents for opioid-sparing analgesia - Navneet K. Grewal, MD
